The QualityStocks Daily Tuesday, May 14th, 2019

Today's Top 3 Investment Newsletters

StockMarketWatch (NBY) +151.72%

SmallCapRelations (TRXD) +47.73%

NetworkNewsWire (PQE) +40.85%

The QualityStocks Daily Stock List

Syncora Holdings Ltd. (SYCRF)

Zacks, ValueWalk, Wallmine, The Learning Investor, Insider Financial, InvestorsHub, Morningstar, Equities, Stockhouse, Equity Clock, Last10k, Wallet Investor, GuruFocus, Capital Cube, Market Screener, and GlobeNewswire reported earlier on Syncora Holdings Ltd. (SYCRF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Syncora Holdings Ltd. is a Bermuda holding company listed on the OTC Markets. Its wholly-owned subsidiary Syncora Guarantee, Inc. provides financial guarantee insurance and reinsurance and credit enhancement for the obligations of debt issuers globally. The Company previously went by the name Security Capital Assurance Ltd. Established in 2006, Syncora Holdings is based in Hamilton, Bermuda.

The Company's leadership consists of professionals with backgrounds in insurance, banking, global finance and law. Syncora's Board of Directors consists of business leaders from the banking, insurance and reinsurance arena.

Syncora Guarantee, Inc. is the New York-based subsidiary. It provides primary financial guarantee insurance to debt issuers around the world.

Syncora guarantees U.S. municipal bonds; asset-backed securities; debt backed by utilities and selected infrastructure projects; specialized risks, including future flow securitizations and bank deposit insurance; and collateralized debt obligations. In addition, the Company invests in private debt and equity securities.

This past March, Syncora Holdings announced that its Board of Directors began a formal review process to explore and evaluate strategic alternatives for the Company centered on optimizing shareholder value and returning capital to shareholders. These alternatives include, among other things, a sale of part or all of Syncora Holdings or its wholly-owned, New York financial guarantee insurance subsidiary, Syncora Guarantee, Inc. The Board is being advised by Moelis & Company LLC, its financial advisor, Debevoise & Plimpton LLP, its U.S. legal advisor, and Appleby, its Bermuda legal advisor.

Yesterday, Syncora Holdings reported financial results for the three months ended March 31, 2019. Selected highlights include Net Premiums Earned of $0.6 million for the three months ended March 31, 2019, versus $14.3 million for the three months ended March 31, 2018. This decrease was mainly because of premiums ceded under the reinsurance agreement with Assured Guaranty Corp., and also $9.6 million of premium accelerations in 2018, versus none in 2019.

Net Investment Income decreased slightly by $1.8 million from $10.4 million for the three months ended March 31, 2018 to $8.6 million for the three months ended March 31, 2019. This decrease was mainly because of lower invested assets as a result of the surplus note payments made during 2018 and from lower income on remediation bonds versus the prior period.

Syncora Holdings Ltd. (SYCRF), closed Tuesday's trading session at $5.14, up 8.21%, on 413,738 volume with 216 trades. The average volume for the last 3 months is 359,775 and the stock's 52-week low/high is $2.72/$5.30.


Harvest Health & Recreation, Inc. (HRVSF)

Profit Confidential, Cannabis Stock Trades, Stock Target Advisor, Street Signals, Stockwatch, Micro Cap Daily, Micro Small Cap, New Cannabis Ventures, Market Screener, Insider Financial, Trading View, Dividend Investor, Proactive Investors, Cannabis Business Times, MarketWatch, Midas Letter, NIC Investors, Stockhouse, and InvestorsHub reported previously on Harvest Health & Recreation, Inc. (HRVSF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Harvest Health & Recreation, Inc. is a vertically integrated cannabis company listed on the OTC Markets' OTCQX. The Company has one of the largest and deepest footprints in the United States. It is a multi-state cannabis operator (MSO) and vertically-integrated cannabis enterprise. Harvest Health & Recreation cultivates, manufactures, and retails cannabis in the U.S. The Company has its corporate office in Tempe, Arizona.

Since 2011, Harvest Health & Recreation has been committed to aggressively expanding its Harvest House of Cannabis retail and wholesale presence across the U.S., acquiring, creating and growing top brands for patients and consumers nationally and continuing on a path of profitable growth. Subject to the completion of announced acquisitions, the Company will have the largest presence in the U.S., with rights to 219 facilities, of which 142 are retail locations and greater than 1,580 employees across 17 States.

Harvest Health & Recreation has been recognized for superior quality with 9 dispensary awards and 5 product awards. The Company's focus is quality product lines, built through meticulous product testing. This results in best-in-class products.

Harvest holds the largest market share in the State of Arizona. The Company has a strong presence in 10 other States. It is on course to have 100 dispensaries in 14 States by 2020.

Recently, Harvest Health & Recreation announced that it signed a Definitive Agreement to acquire Verano Holdings to become one of the most diversified U.S. cannabis operators. It would become the largest multi-state operator (MSO) in the United States following closing of a Definitive Agreement signed on April 22, 2019 to acquire Verano Holdings, LLC, as earlier announced by press release dated March 11, 2019. Verano Holdings is one of the largest privately held multi-state, vertically integrated licensed operators of cannabis facilities with a wide-ranging portfolio of premium branded products.

Last week, Harvest Health & Recreation announced that Mr. Steve White, Company Chief Executive Officer, will deliver a Keynote Address, entitled: "Cannabis Investing Today and Tomorrow: Cutting through the Chatter and Focusing on Basic Financials/Growth Strategies," at the 6th Annual Cannabis World Congress & Business Exposition (CWCBExpo) taking place May 29 – June 1, 2019 at the Javits Center in New York, New York.

Yesterday, Harvest Health & Recreation announced that it closed the first tranche of its earlier announced brokered private placement of 7 percent unsecured convertible debentures of the Company, at a price of US$1,000 per Convertible Debenture for gross proceeds of US$100,000,000. Eight Capital is acting as agent for the offering. Harvest Health & Recreation intends to use the net proceeds of the offering to fund working capital and general corporate purposes.

Mr. White said, "Our vision is to become the most valuable cannabis company in the world and this transaction will help fuel Harvest's growth. This is a particularly acquisitive time in the industry and access to significant capital with favorable terms is crucial to long-term success."

Harvest Health & Recreation, Inc. (HRVSF), closed Tuesday's trading session at $7.825, up 3.78%, on 352,892 volume with 774 trades. The average volume for the last 3 months is 417,919 and the stock's 52-week low/high is $0.075/$10.85.


Cannex Capital Holdings, Inc. (CNXXF)

Stock News Now, Small Cap Power, CannabisMarketCap, Pot Stock News, Midas Letter, Investing News, Stockhouse, InvestorsHub, Trading View, 4-Traders, Private Capital Journal, Financial Content, MarketWatch, Barchart, Dividend Investor, Market Screener, PR Newswire, Stockwatch, Wallet Investor, and Insider Financial reported earlier on Cannex Capital Holdings, Inc. (CNXXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cannex Capital Holdings, Inc., via its subsidiaries, leases real estate properties and sells supplies to cannabis cultivators, processors, and dispensaries in the U.S. and Canada. The Company provides real estate, management, financial, branding and IP (Intellectual Property) support to its increasing portfolio of licensed cannabis business operators. Cannex Capital Holdings lists on the OTC Markets Group's OTCQX. The Company is headquartered in Vancouver, British Columbia.

Cannex Capital is undertaking expansion initiatives to support the acquisition and development of additional assets in legal medical and recreational cannabis markets. The Company currently owns BrightLeaf Development LLC. BrightLeaf holds real estate assets, property leases, IP, and material supply agreements with licensed cannabis businesses. This includes Superior Gardens LLC (d/b/a Northwest Cannabis Solutions), one of the Pacific Northwest's largest full-line cannabis producer/processors.

In November of 2018, Cannex Capital Holdings announced that it signed a binding letter agreement pursuant to which 4Front Holdings, LLC agreed to combine with Cannex Capital in an all-stock transaction. Subject to the approval of the Canadian Securities Exchange (the CSE), the combined company will continue to trade on the CSE initially under Cannex's existing name and the ticker symbol CNNX. The Interim Agreement will be superseded by a Definitive Agreement governing the Transaction.

4Front Holdings, LLC is a foremost retail and brand development company in the U.S. cannabis sector. It has developed a national platform, which comprises a multi-state footprint, including its Mission-branded retail operations, and an extensive network of partnership relationships.

Last month, 4Front Holdings announced the proposed Board of Directors of the new public 4Front company that will survive after the completion of its planned business combination with Cannex Capital. Upon closing, the resulting issuer will be formally named 4Front Ventures Corporation. The Board of 4Front Ventures will initially consists of five Directors, with Cannex Capital and 4Front each appointing one Director and mutually agreeing on three additional directors.

Cannex Capital Holdings, Inc. (CNXXF), closed Tuesday's trading session at $1.12, up 0.90%, on 190,643 volume with 102 trades. The average volume for the last 3 months is 278,680 and the stock's 52-week low/high is $0.378/$2.25.


Cobalt 27 Capital Corp. (CBLLF)

Hottest Stock Picks, Dividend Investor, Market Screener, InvestorsHub, Wallet Investor, Energy and Capital, Streetwise Reports, Barchart, MarketWatch, Proactive Investors, Morningstar, Tip Ranks, Seeking Alpha, Junior Mining Network, Metals News, GuruFocus, and The Street reported previously on Cobalt 27 Capital Corp. (CBLLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cobalt 27 Capital Corp. is a top battery metals streaming company. It offers exposure to metals essential to key technologies of the electric vehicle and energy storage markets. Cobalt 27 Capital's intention is to continue investing in an electric metals-focused portfolio of streams, royalties and direct interests in mineral properties containing cobalt. This is while potentially adding to its cobalt physical holdings when opportunities arise. OTCQX-listed, Cobalt 27 Capital is based in Toronto, Ontario.

Cobalt 27 Capital's strategy of holding physical cobalt, streams and royalties will avoid the operational, environmental, closure and capital risks associated with typical mining companies. Similarly, the Company will not be exposed to any operational risks carried by automakers and battery producers. Through holding physical cobalt and electric metals focused streams and royalties, it will be able to participate in price appreciation while minimizing exposure to risks.

Cobalt 27 Capital owns physical cobalt and a 32.6 percent Cobalt Stream on Vale's world-class Voisey's Bay mine,‎ starting in 2021. The Company is undertaking a friendly acquisition of Highlands Pacific, which is expected to add increased attributable nickel and cobalt production from the long-life, world-class Ramu Mine.

Cobalt 27 also manages a portfolio of 11 royalties. Its acquisition strategy is to fully exploit current market opportunities to invest in streams and royalties and deliver growth as the foremost electric metals investment vehicle.

Cobalt 27 Capital recently provided a status update on its previously announced acquisition of Highlands Pacific Limited, via a definitive scheme implementation agreement, whereby Cobalt 27 proposes to acquire all of the issued ordinary shares of Highlands that it does not own through a scheme of arrangement under Part XVI of the PNG Companies Act in Papua New Guinea (PNG).

Highlands is a mining and exploration company. Its primary assets include an 8.56 percent interest in the producing Ramu mine and a 20 percent interest in the Frieda River Copper-Gold Project, both in PNG. Highlands also holds the Star Mountains Copper Gold exploration project in PNG and has exploration tenements on Normanby Island (Sewa Bay).

Cobalt 27 Capital is now Highlands' single largest shareholder, having increased its equity interest from 13 percent to approximately 19.99 percent during Q1 of 2019. Upon close of the proposed Highlands acquisition, Cobalt 27 Capital will gain an 8.56 percent interest in the producing Ramu nickel-cobalt mine.

Last week, Cobalt 27 Capital announced that the National Court of Papua New Guinea approved the scheme of arrangement on May 2, 2019, under which Cobalt 27 will acquire all the issued share capital of Highlands Pacific Limited. Shares of Highlands have been suspended from trading on the Australian Securities Exchange (ASX) and the Port Moresby Stock Exchange (POMSoX) effective May 3, 2019, pending completion of the Scheme.

Cobalt 27 Capital will participate in the Cobalt Institute Conference and S&P Global Platts Metals Outlook Summit. Cobalt 27, a member of the Cobalt Institute, will be attending the 2019 Cobalt Institute Annual Conference, to be held May 15-16, 2019 in Hong Kong. In addition, Mr. Anthony Milewski, Chairman and Chief Executive Officer of Cobalt 27 Capital, will participate in the panel discussion The Clash of the Titans on Thursday May 16, 2019, at 3:15 pm BST, as part of The Age of Battery Metals program at the Inaugural S&P Global Platts Metals Outlook Summit to be held in London, UK.

Cobalt 27 Capital Corp. (CBLLF), closed Tuesday's trading session at $2.9705, up 0.35%, on 5,184 volume with 35 trades. The average volume for the last 3 months is 21,851 and the stock's 52-week low/high is $2.45/$9.61.


Emerald Health Therapeutics, Inc. (EMHTF)

Micro Cap Daily, Investing Haven, Small Cap Power, Stock of the Week, Green Leaf Pot Stocks, Pot Stock News, Micro Small Cap, Midas Letter, Technical420, New Cannabis Ventures, Stockwatch, Daily Marijuana Observer, NIC Investors, Proactive Investors, Trading View, Wallet Investor, GuruFocus, Insider Financial, Stockhouse, Barchart, and MarketWatch reported previously on Emerald Health Therapeutics, Inc. (EMHTF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQX-listed, Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis in Canada. It is a Health Canada Licensed Producer (LP) of medical cannabis with decades of experience in pharmaceutical innovation. The Company was previously known as T-Bird Pharma, Inc. It changed its name to Emerald Health Therapeutics, Inc. in June of 2015. The Company has its head office in Victoria, British Columbia.

Emerald Therapeutics is part of the Emerald Health group. The Emerald Health group is broadly focused on developing pharmaceutical, botanical, and nutraceutical products, which may provide wellness and medical benefits through interacting with the human body's endocannabinoid system.

Emerald Health Therapeutics' emphasis is on enhancing health through cannabis science. It produces and sells dried cannabis and cannabis oil for medical and recreational purposes. Emerald is a vertically integrated, seed-to-sale company. It has combined core competencies from decades of experience in pharmaceutical innovation with large-scale agriculture expertise centered on developing value-added cannabis-based products with potential wellness and medical benefits.

Emerald is taking advantage of industry-leading life sciences, cannabis and greenhouse growing expertise to attain highly competitive low cost, value-added cannabis products. Emerald entered into a strategic alliance with Factors R&D Technology, Inc., a division of Factors Group of Nutritional Companies, Inc., Canada's largest nutritional supplement marketer and manufacturer. This exclusive arrangement provides access to an industrial-scale production facility, capable of processing up to 1M kg of biomass annually and softgel production capacity of up to 600M capsules annually.

Emerald Health Therapeutics has secured cannabis supply agreements with the provinces of British Columbia, Alberta, Saskatchewan, Ontario, Québec, Newfoundland and Labrador, and the Yukon Territory. The Company is advancing prospective supply agreements with all remaining provinces and territories to develop a major presence in the recreational market.

Emerald purchased 500 acres of harvested hemp chaff in 2018 and up to 1,000 acres in 2019 to 2022 from Emerald Health Hemp, Inc. CBD extract from hemp biomass will be used in the Company's medical and adult-use products.

Last month, Emerald Health Therapeutics announced that its 50 percent-owned joint venture (JV), Pure Sunfarms, completed planting of the final quadrants of its 1.1 million square foot Delta 3 greenhouse operation in Delta, British Columbia. Therefore, the entire 1.03 million square feet of growing area at Delta 3, consisting of 16 individual grow rooms, is on course to reach its annualized full production run-rate of 75,000 kilograms by mid-2019.

Emerald's 50 percent-owned Pure Sunfarms JV in British Columbia is licensed to cultivate in 1.03 million square feet of the first of its two 1.1 million square foot greenhouses. The capacity of each greenhouse is estimated to surpass 75,000 kg of cannabis per year. Emerald's Verdélite operation in Québec is completing the build out of its 88,000 square foot indoor cultivation facility and is scaling up production. Emerald's Q4 sales of $1.1 million was more than triple the prior quarter and year-over year. Q1 2019 sales were $2.6 million.

Emerald Health Therapeutics, Inc. (EMHTF), closed Tuesday's trading session at $2.706, up 0.97%, on 149,074 volume with 432 trades. The average volume for the last 3 months is 445,286 and the stock's 52-week low/high is $1.48/$4.50.


Hut 8 Mining Corp. (HUTMF)

Investor Ideas, Small Cap Power, OTC Markets, Cryptocredits, CoinNews Telegraph, Invest Tribune, Stockwatch, Market Screener, Wallet Investor, 4-Traders, Investorx, YCharts, InvestorsHub, Midas Letter, Trading View, MarketWatch, Seeking Alpha, Morningstar, Barchart, and Stockhouse reported earlier on Hut 8 Mining Corp. (HUTMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Hut 8 Mining Corp. is one of the world's largest publicly traded cryptocurrency mining companies by operating capacity and market capitalization. It has industrial scale bitcoin mining operations in Canada. The Company provides investors with direct exposure to bitcoin, without the technical complexity or constraints of buying the underlying cryptocurrency. Therefore, investors avoid the need to create online wallets, wire money offshore, and safely store their bitcoin. OTCQX-listed, Hut 8 Mining's registered office is in Vancouver, British Columbia.

The Company has an exclusive North American partnership with the Bitfury Group Limited, inclusive of Bitfury Holding BV, (Bitfury), one of the world's foremost full-service hardware and software blockchain technology companies. The Bitfury Group's expertise ensures successful, secure, as well as cost-effective connectivity to the blockchain. Bitfury provides turn-key service to install, service and maintain BlockBox datacenters.

Hut 8 Mining has an exclusive option for the future acquisition and development of datacenters and a wide-ranging and proprietary mix of hardware, software, installation and operational services in North America. Regarding secured, low cost electricity, it is operating 95.2 MW in Drumheller and Medicine Hat, Alberta, with access to additional power in Canada.

In Medicine Hat, Alberta, 56 BlockBox datacenters are operating at a maximum capacity of 62.7 MW and 504 PH/s at full load. Furthermore, in Drumheller, Alberta, 29 BlockBox datacenters are operating at a maximum capacity of 32.5 MW producing 280 PH/s at full load.

Last week, Hut 8 Mining announced its financial results for the year ended December 31, 2018. The Company realized record Revenue of $49.4 million from mining 5,592 bitcoin for 2018. It had Adjusted EBITDA (Earnings Before Interest, Tax, Depreciation and Amortization) of $19.3 million for the 2018 year with an Adjusted EBITDA margin of 39 percent.

Hut 8 Mining expanded its operations from 7 to 85 BlockBox data centers through 2018. It also increased PH/s capacity by 1,300 percent from 56 to 784 PH/s. In addition, Hut 8 entered into a definitive agreement with the City of Medicine Hat for the supply of 42 MW and 21 MW of additional off-grid energy. The Company also completed its flagship site in the City of Medicine Hat. This represents an increase of 63 MW of operating capacity for an aggregate of 95.2 MW in operation at year end.


Hut 8 Mining Corp. (HUTMF), closed Tuesday's trading session at $1.6011, up 1.02%, on 90,790 volume with 88 trades. The average volume for the last 3 months is 14,185 and the stock's 52-week low/high is $0.599/$3.21.


Q BioMed, Inc. (QBIO)

NetworkNewsWire, Zacks, TipRanks, Proactive Investors, Market Screener, Market News Updates, Barchart, Simply Wall St, Wallet Investor, Stockwatch, PR Newswire, Marketbeat, Insider Financial, InvestorsHub, and Stockhouse reported previously on Q BioMed, Inc. (QBIO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Q BioMed, Inc. is a biotechnology acceleration company headquartered in New York, New York. The Company acquires, develops and finances undervalued biomedical assets. Q BioMed's corporate vision is to create a pipeline of unique biomedical assets in diverse stages of development in numerous therapeutic areas. Q BioMed lists on the OTC Markets OTCQB.

The Company is working to expedite the monetization of biomedical technologies via fast innovation and collaborative partnerships with industry leading researchers. Q BioMed's belief is that its assets in oncology, vascular disease, and rare orphan diseases address unmet medical needs and large markets.

Q BioMed's Food and Drug Administration (FDA) approved, non-opioid drug is Metastron. It relieves cancer bone pain. The expectation is that it will start producing revenues this year. In addition, Metastron is approved for sale in 21 other countries. Further to treating pain, Metastron has shown evidence of treating the cancer itself and extending survival. Q BioMed's plan is to conduct Phase IV trials to support label extension and cancer survival benefit using Metastron.

Q BioMed also has its QBM-001 for Pediatric Non-Verbal Disorder in dire need of treatment. The Company plans to submit a Pre-IND and Orphan Drug filing with the FDA in the coming quarter with a goal to initiate a clinical trial in Q3 2019.

Q BioMed also has its Uttroside-B. Uttroside-B is up to 10 times more potent against liver cancer cells than Sorafenib (preclinical data), the only FDA approved drug for first line treatment of liver cancer. The Company plans to file an IND with the FDA this year to begin a clinical trial in this indication.

Furthermore, Q BioMed has its Man-01 to treat glaucoma. Man-01 has shown to normalize Intraocular Eye Pressure (IOP) which is present in glaucoma patients. The Company expects to submit an IND to the FDA this year. The Mannin platform has a number of potential drugs for treating vascular disease.

Last month, Q BioMed announced the discovery of two novel biomarkers for pediatric nonverbal autism, identified in a subset of children with Autism Spectrum Disorder (ASD). This marks the first time a company has been able to identify biomarkers, which hold the potential to stratify this subset of children. The study took into consideration 1,953 potential biomarkers and used Vineland II scores to stratify 240 children into three groups: verbal, semi-verbal, and nonverbal autism.

Q BioMed Chief Executive Officer, Denis Corin, said, "This is a major breakthrough for these children and their families. To date, very little attention and research has been focused on these nonverbal autistic children. In partnership with the clinical and advocacy community, Q BioMed is leading the effort to better stratify this group, while also pursuing a treatment."

Q BioMed, Inc. (QBIO), closed Tuesday's trading session at $1.63, up 7.24%, on 24,120 volume with 42 trades. The average volume for the last 3 months is 45,859 and the stock's 52-week low/high is $0.89/$3.65.


Powerbridge Technologies Co., Ltd. (PBTS)

Stock Trends, Market Tamer, Stock Twits, Street Insider, Zacks, Last10k, GlobeNewswire, GuruFocus, YCharts, Stockwatch, Investors Hangout, Stockhouse, Trading View, and Market Screener reported earlier on Powerbridge Technologies Co., Ltd. (PBTS), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Powerbridge Technologies Co., Ltd. is a worldwide trade software application and technology services provider. The Company is a provider of software application and technology solutions and services to corporate and government customers mainly located in China. Established in 1997, Powerbridge Technologies pioneered worldwide trade software applications with a vision to make global trade operations easier for customers. Powerbridge Technologies has its corporate headquarters in Zhuhai, China.

Powerbridge Technologies offers Powerbridge System Solutions that include Trade Enterprise and Trade Compliance, and also Import & Export Loan and Insurance Processing for customers to streamline their trade operations, trade logistics, and regulatory compliance. In addition, the Company provides Powerbridge Software-as-a-Service solutions that include Logistics Service Cloud and Trade Zone Operations Cloud, and also Inward Processed Manufacturing Cloud, Cross-Border eCommerce Cloud, and Import & Export Loan and Insurance Processing Service Cloud.

Powerbridge System Solutions and Powerbridge Saas Services feature comprehensive and strong customized solutions and packaged products. These allow customers to streamline and optimize operations in regulatory compliance, trade logistics and trade financing. The Company's solutions and services have been deployed and used by thousands of corporate and government customers engaged in international trade. Powerbridge sells its solutions and services by way of its direct sales organization, indirect channel partners, and strategic government partners.

Earlier this month, Powerbridge Technologies announced the closing of the Initial Public Offering (IPO) of 1,750,000 ordinary shares, par value $0.00166667 per share, at a price of $5.00 per share. Powerbridge's ordinary shares commenced trading on the Nasdaq Capital Market on April 2, 2019 under the symbol "PBTS."

The Company received aggregate gross proceeds of roughly $8,750,000 from the IPO. Proceeds from the IPO will be used for research and development (R7D), sales and marketing, strategic alliances and acquisitions, and working capital and general corporate purposes. Furthermore, Powerbridge has granted the underwriters a 45-day option to purchase up to an additional 262,500 ordinary shares.

Powerbridge Technologies Co., Ltd. (PBTS), closed Tuesday's trading session at $4.91, up 2.08%, on 11,020 volume with 58 trades. The average volume for the last 3 months is 234,462 and the stock's 52-week low/high is $4.28/$7.85.


Gran Colombia Gold Corp. (TPRFF)

Gold Stock Data, Market Screener, Canadian Mining Report, Metals News, Stockhouse, GlobeNewswire, InvestorsHub, Wallet Investor, Junior Mining Network, Equity Clock, and Investors Hangout reported previously on Gran Colombia Gold Corp. (TPRFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Gran Colombia Gold Corp. is a mid-tier gold producer headquartered in Toronto, Ontario. The Company's main focus is in Colombia where it is presently the largest underground gold and silver producer with a number of mines in operation at its Segovia and Marmato Operations. Gran Colombia is continuing to center on exploration, expansion and modernization activities at its high-grade Segovia Operations. The Company lists on the OTC Markets' OTCQX.

Gran Colombia Gold is building a strong production growth profile by way of exploration, development and bringing to production gold projects in Colombia. Its emphasis is on the development of the Segovia Operations and Marmato projects to generate strong cash flows in the short, medium and long term.

The Company produces gold from the Segovia Operations, an area of roughly 9,000 hectares in the Segovia-Remedios mining district of Antioquia. The Segovia Operations include the El Silencio, Providencia and Sandra K underground mines in the Municipality of Segovia, and the Carla underground mine in the Municipality of Remedios, situated about 10 km southeast of the Segovia mines.

The Marmato Project contains total estimated resources of roughly 8 million ounces of gold and almost 38 million ounces of silver positioned in the Caldas department in the core of the Middle Cauca gold district. The Marmato Project has first-rate infrastructure, being located by the Pan American Highway with access to Medellin to the north and Manizales to the south. The Project also has access to the national electricity grid that runs near the property.

Gran Colombia Gold also has its Zancudo Project. It is in the Titiribí mining district of Antioquia. Zancudo consists of an historical gold mine, the Independencia Mine, in the Middle Cauca Gold Belt, which produced approximately 130,000 ounces of gold with recovered grades of 14.6 g/t Au and 108.4 g/t Ag.

Gran Colombia Gold halted further exploration work on the Zancudo property following the gold price collapse in 2013 to concentrate on the modernization project at its Segovia Operations. The Company announced in March of 2017 that it signed an option agreement with IAMGOLD Corp. for the exploration and potential purchase of an interest in the Zancudo Project.

Last week, Gran Colombia Gold announced that it produced a total of 21,325 ounces of gold in March 2019. This brings the total for Q1 of 2019 to 60,601 ounces, a new quarterly record and up 15 percent over Q1 of 2018. This brings the trailing 12 months' total gold production at the end of March 2019 to 225,930 ounces. This is up 4 percent over 2018's annual production and at the top end of Gran Colombia Gold's guidance range for 2019 of between 210,000 and 225,000 ounces.

Gran Colombia Gold will release its financial results for Q1 of 2019 after market close on Wednesday, May 15, 2019. The Company will host a conference call and webcast on Thursday, May 16, 2019 at 9:30 a.m. Eastern Time to discuss the results.

Gran Colombia Gold Corp. (TPRFF), closed Tuesday's trading session at $2.45, up 1.24%, on 4,804 volume with 10 trades. The average volume for the last 3 months is 24,277 and the stock's 52-week low/high is $1.566/$3.44.


Rubicon Organics, Inc. (ROMJF)

CannabisFN, Investorx, Investor Ideas, PR Newswire, Investor News, Pot Stock News, Stockhouse, Trading View, Stockwatch, Market Screener, Biospace, The Street, and Investors Hangout reported earlier on Rubicon Organics, Inc. (ROMJF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Rubicon Organics, Inc. is a super-premium, organic cannabis producer with operations in Canada, Washington and California. The Company is a Licensed Producer (LP) and its flagship Canadian facility is a 125,000 sq. ft. state-of-the-art hybrid greenhouse with industry leading LED lighting. This facility is situated on a 20-acre property in Delta, British Columbia. Furthermore, Rubicon Organics owns two award-winning U.S. cannabis brands. These are 1964 Supply Co. (TM) in California and Doctor & Crook Co. (TM) in Washington. OTCQX-listed and founded in 2015, Rubicon Organics is based in Vancouver, British Columbia.

Rubicon's Washington facility is a newly constructed, 40,000 sq. ft. hybrid greenhouse and extraction facility. The Company has started production in both facilities with a combined Phase I capacity of 15,500 kg per year. This includes 4,500 kg leased to a Washington State licensed operator applying Rubicon Organics' proprietary organic cultivation methods (Organic certification pending from FVOPA).

The Company's plants are grown in proprietary soil made with certified organic ingredients. Each stage of the growing process is carried out by hand - from planting to packaging. Rubicon's process replicates outdoor growing techniques. The process is supervised by skilled and knowledgeable growers. Moreover, everything that goes into its plants comes from the ground and the ocean.

Rubicon Organics is the first cannabis operation in Canada to complete an Environmental Farm Plan. This comprises 100 percent rainwater collection and recycling; carbon capture and reuse; and net-zero energy and waste.

Last month, Rubicon Organics announced that its 125,000 sq. ft. licensed facility in Delta, British Columbia started preparation for its European Union - Good Manufacturing Practices (EU-GMP) certification. The EU-GMP certification is given to companies who demonstrate a high degree of precision and consistency in their manufacturing procedures. It is a requirement for the import of medical cannabis products into the European market.

In addition, last month, Rubicon Organics announced its membership in the Global Cannabis Partnership (GCP). The Global Cannabis Partnership is a collaboration of leaders in the government-sanctioned adult-use recreational cannabis industry. It has representation from government, private-sector and affiliate organizations. The GCP works to create global standards for the safe and responsible production, distribution and consumption of legal recreational cannabis.

Rubicon Organics, Inc. (ROMJF), closed Tuesday's trading session at $2.20, up 1.98%, on 4,000 volume with 7 trades. The average volume for the last 3 months is 4,260 and the stock's 52-week low/high is $1.298/$2.50.


Gulf Keystone Petroleum Limited (GUKYF)

Small Cap Network, 4-Traders, Investing Online, Trading View, Real Investment Advice, Equity Clock, Market Screener, MarketWatch, Wallmine, Dividend Investor, Whale Wisdom, Value Forum, The Street, Wallet Investor, and Stockhouse reported earlier on Gulf Keystone Petroleum Limited (GUKYF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Incorporated in Bermuda in 2001, Gulf Keystone Petroleum Limited is a foremost independent operator and producer in the Kurdistan Region of Iraq. The Company is the operator of the Shaikan oil field with present production capacity of 40,000 barrels of oil per day. In 2009, Gulf Keystone Petroleum discovered the Shaikan field. The Company also provides geological, geophysical, and engineering services. Gulf Keystone Petroleum lists on the OTC Markets Group's OTCQX. The Company has its corporate office in Hamilton, Bermuda. It has further offices in Erbil, Kurdistan Region of Iraq; and London, United Kingdom (UK).

Gulf Keystone has a first-rate track record of demonstrated drilling and operating successes in the Kurdistan area of Iraq. The Company's strategy is to move to the large-scale staged development of the Shaikan field. Its near-term strategy is to maintain production from Shaikan production facilities at 40,000 bopd, with a view to expanding to 55,000 bopd, and further beyond. The Shaikan block is positioned approximately 60 km to the north-west of Erbil covering an area of 283 km².

Gulf Keystone Petroleum International Ltd. (GKPI), a wholly-owned subsidiary of Gulf Keystone Petroleum Limited, holds an interest in the Shaikan Block Production Sharing Contract (PSC), where it is the operator. On August 6, 2009, Gulf Keystone announced a major discovery with the Shaikan-1 exploration well. It declared Shaikan a commercial discovery in August of 2012. The Shaikan Field Development Plan was approved in June of 2013.

Gulf Keystone Petroleum has been present in the Kurdistan region since 2007. The Company works closely with the Ministry of Natural Resources, one of its partners on the Shaikan field. This is to attain its joint goal of developing the resources for the broader benefit of the region, and all of its stakeholders.

Gulf Keystone Petroleum believes there is significant growth potential for the Shaikan Field. Material oil volumes are in the Cretaceous, Jurassic and Triassic formations. At present, production is from Jurassic only. A staged approach is being undertaken to de-risk field long-term potential.

Gulf Keystone Petroleum Limited (GUKYF), closed Tuesday's trading session at $3.16, up 0.32%, on 339 volume with 7 trades. The average volume for the last 3 months is 1,139 and the stock's 52-week low/high is $2.05/$3.98.


Ivanhoe Mines Ltd. (IVPAF)

Stock News Union, Stockhouse, MarketWatch, 4-Traders, Wallet Investor, Market Screener, Investors Hangout, Marketbeat, Dividend Investor, Equity Clock, StreetWise Reports, InvestorsHub, Insider Financial, Trading View, YCharts, and Street Insider reported previously on Ivanhoe Mines Ltd. (IVPAF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Ivanhoe Mines Ltd. engages in the exploration, development, and recovery of minerals and precious metals located mainly in Southern Africa. The Company previously went by the name Ivanplats Limited. It changed its corporate name to Ivanhoe Mines Ltd. in August of 2013. OTCQX-listed, Ivanhoe Mines has its head office in Vancouver, British Columbia.

The Company is centering on advancing its three main projects in Southern Africa: the development of new mines at the Kamoa-Kakula copper discovery in the Democratic Republic of Congo (DRC) and the Platreef palladium-platinum-nickel-copper-gold discovery in South Africa; and the wide-ranging redevelopment and upgrading of the historic Kipushi zinc-copper-germanium-silver mine, also in the DRC.

The Kamoa-Kakula Copper Project - a joint venture (JV) between Ivanhoe Mines (39.6 percent), Zijin Mining Group (39.6 percent), Crystal River Global Limited (0.8 percent) and the Government of the Democratic Republic of Congo (20 percent) - has been independently ranked as the world's largest, undeveloped, high-grade copper discovery by global mining consultant Wood Mackenzie.

Ivanhoe Mines indirectly owns 64 percent of the Platreef Project via its subsidiary, Ivanplats, and is directing all mine development work. The South African beneficiaries of the approved broad-based, black economic empowerment structure have a 26 percent stake in the Platreef Project. The remaining 10 percent is owned by a Japanese consortium of ITOCHU Corporation; Japan Oil, Gas and Metals National Corporation; and Japan Gas Corporation.

The Kipushi Project is a JV between Ivanhoe Mines and the DRC state-owned mining company, La Générale des Carrières et des Mines (Gécamines). In addition, Ivanhoe Mines is exploring for new copper discoveries on its wholly-owned Western Foreland exploration licences. These licenses are adjacent to the Kamoa-Kakula mining licence. Ivanhoe Mines' DRC exploration group is targeting Kamoa-Kakula-style copper mineralization by way of a regional exploration and drilling program on its 100 percent-owned Western Foreland exploration licences.

Recently, Ivanhoe Mines announced that it filed an updated National Instrument 43-101 (NI 43-101) technical report covering the June 2018 Mineral Resource estimate for the Kipushi Project in the DRC. The technical report was independently prepared by OreWin Pty Ltd., The MSA Group (Pty) Ltd., SRK Consulting (South Africa) (Pty) Ltd., and MDM (Technical) Africa Pty Ltd. (a division of Wood PLC).

The technical report titled "Kipushi 2019 Mineral Resource Update" was filed on the SEDAR website at and on the Ivanhoe Mines website at

Ivanhoe Mines Ltd. (IVPAF), closed Tuesday's trading session at $2.47, up 4.83%, on 96,289 volume with 118 trades. The average volume for the last 3 months is 109,911 and the stock's 52-week low/high is $1.50/$2.77.


TerrAscend Corp. (TRSSF)

Street Signals, Hottest Stock Picks, Profit Confidential, GuruFocus, Small Cap Power, Energy and Capital, MicroCapDaily, Trading View, Financial Content, CannabisMarketCap, Market Screener, The Seed Investor, Wallet Investor, Midas Letter, New Cannabis Ventures, Barchart, Seeking Alpha, The Street, MarketWatch, and Stockhouse reported earlier on TerrAscend Corp. (TRSSF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

TerrAscend Corp. is a biopharmaceutical and wellness company listed on the OTC Markets Group's OTCQX. The Company's commitment is to quality products, brands, and services for the worldwide cannabinoid market. TerrAscend participates in the medical and legal adult-use market in Canada and in U.S. states where cannabis has been legalized for therapeutic or adult-use. The Company has its corporate office in Mississauga, Ontario.

TerrAscend operates several synergistic businesses. These include Arise Bioscience, Inc., a manufacturer and distributor of hemp-derived products, Ascendant Laboratories, Inc., a biotechnology and licensing Company dedicated to the continuous improvement of cannabinoid expressing plants, and Solace RX, Inc., a proposed drug preparation premises centered on the development of novel formulations and dosage forms. TerrAscend's brands include Haven St. Premium Cannabis; and Knüba Naturals, which is a line of premium cannabis products.

The Company has its facility built to GMP requirements. The facility is 67,300 sq. ft., located in Mississauga. It features premium hydroponic cultivation and products are lab tested to the highest standards. The facility has sterile & non-sterile drug compounding capabilities.

This past January, TerrAscend announced the closing of the earlier reported asset acquisition of Grander Distribution, LLC. Grander is an industry leader in the production and distribution of unique hemp-derived wellness products. Grander's whole-plant hemp extract products are made in the United States and are available for sale in approximately 10,000 retail locations around the world.

Recently, TerrAscend announced the signing of definitive securities purchase agreements facilitating a major investment in three entities in California operating the award-winning retail dispensary brand known as "The Apothecarium". In addition, the purchase agreements include the acquisitions of a vertically integrated operation in Nevada with cultivation, edible manufacturing and an Apothecarium retail location, and also Valhalla Confections, a provider of top premium edible products.

Last month, TerrAscend announced preliminary Q4 and full year revenue ending December 31, 2018 of CAD$4.8 million and CAD$6.6 million, respectively. Audited year end results will be published on the morning of April 25, 2019 followed by an Investor Day where TerrAscend will provide full year 2019 financial guidance.

TerrAscend Corp. (TRSSF), closed Tuesday's trading session at $2.45, up 1.24%, on 4,804 volume with 10 trades. The average volume for the last 3 months is 24,277 and the stock's 52-week low/high is $1.566/$3.44.


Pulse Evolution Group, Inc. (DGLF)

TMX Money, Stockhouse, Street Insider, Morningstar, Seeking Alpha, InvestorsHub, Simply Wall St, Barchart, GlobeNewswire, Guru Focus, OTC Markets, and Investors Hangout reported on Pulse Evolution Group, Inc. (DGLF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Pulse Evolution Group, Inc. is a foremost developer of hyper-realistic digital humans and characters for entertainment, mixed reality and artificial intelligence (AI). In August 2018, the Company acquired Evolution AI Corporation, a developer of digital humans as an 'inter-Face' of AI applications. This included its majority interest in Pulse Evolution Corporation (PLFX).

Pulse Evolution Group lists on the OTC Markets OTCQB and the Company has its head office in New York, New York. It previously went by the name Recall Studios, Inc. It changed its corporate name to Pulse Evolution Group, Inc. in February of this year.

Pulse engages in the development of human animation technology to enable AI platforms to interact with consumers in the relatable form of human faces and human characters. The Company also engages in the development of hyper-realistic digital humans and computer-generated assets that perform in live shows, virtual reality, augmented reality, holographic, 3D stereoscopic, Web, mobile, interactive, and AI applications. It also engages in the storage, protection, and distribution of virtual facebanks.

Pulse Evolution Group centers on creating software and experiential applications that elevate the way consumers interact with content. The Company's main strategy has been focused on the growing market of Mixed Reality (virtual reality and augmented reality) with a portfolio of proprietary technology (including two patents pending), which is ready for market and scheduled for commercial introduction.

This week, Pulse Evolution Group announced it has been added to the roster of leading partners for Broadway Asia's theatrical production of DreamWorks' Kung Fu Panda Spectacular Live at the Venetian Theatre in Macau.

Mr. John Textor, Pulse Evolution Group's Chief Executive Officer, said, "We are delighted to have been asked to join this incredible group of people and companies in such a highly anticipated DreamWorks' production. Producers Simone Genatt and Marc Routh are among the most experienced and successful theatrical producers in Asia and they have assembled a first-class team, along with director Susan Stroman, to bring Asia's most successful animation franchise to life in a way that will leave audiences with memories for a lifetime."

Pulse Evolution Group, Inc. (DGLF), closed Tuesday's trading session at $5.50, up 2.61%, on 301 volume with 29 trades. The average volume for the last 3 months is 666 and the stock's 52-week low/high is $3.29/$23.625.


The QualityStocks Company Corner

Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGRMF).

Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF) was highlighted by Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, which today announced the agenda for the upcoming Cannastocks2019 Q1 Virtual lnvestor Conference. Also today, the company was highlighted in an article published by One Equity Stocks looking at how thirty eight state attorneys general are ready to bring the booming marijuana industry mainstream, and they want big banks and regulators on board.

Organigram Holdings Inc. (TSX.V: OGI) (OTC: OGRMF) is the parent company of Organigram Inc., an original and leading Canadian licensed producer ("LP") of premium, quality cannabis and extract-based products. Founded in 2013 and headquartered in Moncton, New Brunswick, Canada, Organigram is focused on producing the highest-quality indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company's global footprint. 

Organigram delivers industry-leading yields and maximizes cannabis production at the lowest cultivation cost among other Canadian licensed producers. Organigram's high-tech facilities utilize an efficient, state-of-the-art mechanical room that includes both ethanol and CO2 extraction methods.

The company first began as a medical cannabis provider producing 5,000 kg/year (11,000 lbs) of 100 percent organic cannabis grown in pre-fabricated grow pods. Within two years, Organigram increased production to 36,000 kg/year (70,000 lbs) by utilizing an inventive, indoor 3-tier growing system. The company's pharmaceutical grade, state-of-the-art facility currently houses over 45,000 flowering plants growing at any one time.

Organigram's head office, production facility and research & development program are located on the company's 14-acre campus that houses several buildings and a 40-megawatt substation. Leading the way with a proprietary software system that acts as the nervous system of the entire organization, Organigram's team employs a data-driven decision-making process that ensures efficiency and top yields. Numerous design and automation improvements include an ergonomically friendly grow room design, automatic potting machines and automated packaging lines, and larger propagation rooms with advanced environmental systems.

Organigram's fully funded Phase 4 expansion is underway which, when complete by fall of 2019, will bring production capacity of high-quality premium cannabis to 113,000 kg/year (249,000 lbs). The Company has also invested in Hyasynth, a Montreal-based biotechnology company and leader in the field of cannabinoid science and biosynthesis. Hyasynth has developed a disruptive technology using patented enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation.

Organigram expects to double its workforce within the year to accommodate increasing growth as the facility expands to 480,000 square feet of production space at full buildout. In September 2017, Organigram signed the first ever recreational cannabis supply agreement in Canada with the Province of New Brunswick. Since then, Organigram has signed similar supply agreements with nine out of 10 provinces, has already exported product out of Canada, and is currently working with German medical cannabis provider, Alpha-cannabis, and Serbia-based Eviana Health Corp. (CSE: EHC), a hemp farm and processing facility.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado, with 16 retail locations, for development of commercial scale extraction and product processing, along with derivative product development (edibles, vaporizable products and beverage product mixes). Organigram's partnership with Canada's Smartest Kitchen, a leader in food product development, will expand and develop the Company's edibles R&D program and creation of premium chocolate products. Organigram has also signed a multi-year extraction contract with Valens GroWorks Corp. for Valens to produce extract concentrate for oils and derivative products.

Organigram is well-positioned in the cannabis space with several adult-use recreational product lines. These include:

  • Trailblazer offers a consistent value with a pre-roll, milled format
  • Trailer Park Buds provides niche equity for mainstream users that seek pre-rolls
  • Ankr Organics offers premium, organic pre-roll and oils
  • Edison Cannabis Co. delivers robust, high THC in a whole flower, pre-roll and oil produced from premium sorted flowers
  • Edison Cannabis Co. Reserve offers an ultra-premium, large whole flower that is craft cured and hand trimmed

Experienced Executive Team

  • CEO Gregory Engel has more than 30 years of experience in the pharmaceutical industry with over three years of experience as a CEO for a cannabis company.
  • Jeff Purcell, senior vice president of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods.
  • Tim Emberg, senior vice president of sales and commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and consumer packed good industry.
  • Guillermo Delmonte, president of international operations, brings experience in leading a global cannabis company and worked for 2.5 years as CEO of ICC Labs Inc. in Uruguay.
  • Larry Rogers, vice president of international operations, has held roles for Organigram since 2014 including being a member of the board of directors, chief operating officer and vice president/business development.
  • Paolo DeLuca, chief financial officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities.
  • Ray Gracewood, chief commercial officer, has 15 years of experience in the marketing space and is a previous senior director of sales and marketing for Moosehead Breweries Ltd.
  • Michael Tripp, chief legal officer, worked for private practices at respected business law firms in Moncton and Toronto where he acted on over $3 billion in transactions.

Organigram Holdings Inc. (OTCQX: OGRMF), closed the day's trading session at $7.0934, up 2.80%, on 631,328 volume with 1,399 trades. The average volume for the last 3 months is 884,349 and the stock's 52-week low/high is $2.97/$7.723.

Recent News


Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) was highlighted today in a publication from, examining how, over the last year, Canada approved cannabis. More U.S. states are legalizing its recreational or medicinal use and corporate America is using CBD and hemp oil in everything from lotions and pain balm to beverages.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $4.40, up 5.01%, on 554,046 volume with 1,094 trades. The average volume for the last 3 months is 527,440 and the stock's 52-week low/high is $2.40/$11.82.

Recent News


The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) is pleased to announce that it has obtained approval from Health Canada, under the Cannabis Regulations, to expand operations into its new state-of-the-art building located in Hamilton, Ontario. The 20,000 square feet indoor facility is going to be used for cannabis cultivation; planting will start in the coming weeks. Also today, NetworkNewsWire released a report on the company detailing how TGODF seems to have all the right boxes ticked as it pursues a relentless quest to become the world's leading provider of organic cannabis. Additionally, the company was highlighted in a publication from, examining how over the last year, Canada approved cannabis. More U.S. states are legalizing its recreational or medicinal use and corporate America is using CBD and hemp oil in everything from lotions and pain balm to beverages.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.85, off by 0.07%, on 714,873 volume with 1,426 trades. The average volume for the last 3 months is 1,210,072 and the stock's 52-week low/high is $1.61/$7.894.

Recent News


Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today the signing of a distribution agreement with Cornes Technologies, a leading Japanese trading house. According to the agreement, Cornes Technologies will have exclusive rights to promote and sell Foresight's QuadSight™ system in Japan. Cornes Technologies, a renowned trading company, plays a significant role in establishing and developing commercial links and trade between Japan and the rest of the world.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $1.18, up 2.61%, on 411,605 volume with 857 trades. The average volume for the last 3 months is 46,147 and the stock's 52-week low/high is $1.129/$4.43.

Recent News


Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

Trxade Group, Inc. (OTCQB: TRXD), Trxade is an integrated pharmaceutical logistical services company that combines a web-based purchasing platform for transactions between independent pharmacists and drug manufacturers, E-Hub with a mail order pharmacy, warehouse and drug delivery services for consumers nationwide, today reported financial results for its first quarter, ended March 31, 2019 and provided a business update and positive outlook for 2019.

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform ( for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!


Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" ( which enables SAME DAY home delivery of dispensed prescriptions.


Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed the day's trading session at $0.65, up 47.73%, on 1,049 volume with 10 trades. The average volume for the last 3 months is 71,511 and the stock's 52-week low/high is $0.026/$0.1397.

Recent News


Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) was highlighted today in a report by Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced the agenda for the upcoming Cannastocks2019 Q1 Virtual lnvestor Conference.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.


Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.554, up 2.88%, on 334,980 volume with 164 trades. The average volume for the last 3 months is 772,617 and the stock's 52-week low/high is $0.189/$1.875.

Recent News


Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) was featured today in the 420 with CNW by CannabisNewsWire.

Headquartered in Vancouver, Canada, with operations in San Diego, Calif., Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)  is a premium food and beverage company that focuses on whole plant nutrition and natural ingredients that help best maintain overall health and balance in the human body. The company infuses active hemp into a variety of premium foods, beverages and supplements and is poised for global distribution. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s mission is to become a leader in whole plant solutions by providing holistic remedies for a more natural alternative to pharmaceuticals and by guiding people toward a healthy lifestyle. Phivida embraces and celebrates a return to organic, natural, plant-based foods and beverages and a focus on holistic health and wellness.

Publicly traded on the Canadian Securities Exchange (CSE: VIDA) and the OTCQX Best Market in the U.S. (OTC: PHVAF), the company’s strong balance sheet carries CAD$13 million with no debt or loans with ~60 million shares outstanding, and the company is now well-capitalized to fund major mainstream distribution with a solid structure that is poised for long-term growth.


Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who, as Phivida’s chief commercial officer, is tasked with driving new sales revenue growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

The whole plant hemp extract is infused into functional beverages, food and supplements to target a range of health and wellness conditions. Phivida strives to lead the industry in product quality through high-quality ingredients and best-in-class testing. The Company has partnered with Flora Labs to test and ensure consistency and potency of all products. Flora Labs is a world-class testing lab with stringent QA and QC quality assessment protocols and will provide Phivida with ongoing impartial quality testing.


Federally legal under the 2014 Farm Bill, CBD from hemp oil is a rapid growth market across the U.S. When derived from marijuana, CBD remains a schedule 1 controlled substance, giving hemp-derived CBD oil-infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the U.S. Industrial Hemp laws to an agricultural commodity status and effectively removing hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the U.S. CBD-hemp sector. In February 2018, the Supreme Court presided over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp and the legality of industrial hemp. In the final ruling, the Supreme Court unequivocally determined that hemp (and its derivatives), when produced domestically under the Farm Bill, are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA), giving the Farm Bill primary jurisdiction over the governance of the CBD-hemp oil industry in the U.S.

The DEA further conceded it does not “seek to control cannabinoids” and that only marijuana-derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g., U.S. Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreational cannabis, with edibles to be added in 2019. The bill officially became law as of Oct. 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

Phivida Brands

  • Vida+: Vida+ is the company’s premium, clinical-grade-strength, full-spectrum hemp oil extract and capsule line designed to help people feel their best. The products are sourced from the best organic hemp and natural ingredients on the market and are third-party lab tested for quality, purity and potency at world-class facilities.
  • Oki: The Oki lifestyle brand is the company’s newly launched line of functional beverages and supplements infused with active hemp extract and will be available to consumers in up to 2,400 natural specialty store locations within the United States. Oki beverages are infused with 10 milligrams of active hemp extract per bottle and come in two different formulations: iced teas and flavor-infused water, each available in four different 16-ounce flavors. Oki supplements are available in tinctures or capsules that range in doses from 600-1,800 total milligrams of active hemp extract.
  • All products contain non-GMO, natural and organic ingredients and are plant-based and vegan friendly and packaged in sleek, 100 percent recyclable glass containers.

WeedMD-Phivida Joint Venture

Phivida has partnered with WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on manufacturing, marketing and distributing cannabinoid-infused beverages. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distributing cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets. WeedMD will be the exclusive cannabis supplier and distributor for CanBev cannabis-infused beverages. Phivida will be responsible for product innovation, research and development, formulation and branding.

Strategic Agreements

Phivida has an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. NSS is recognized as the industry leader in natural/specialty retail channel trade across the U.S. Phivida’s launched OKI brand of premium CBD products is now the exclusive CBD-infused beverage and health supplements products brand represented by NSS. This establishes Phivida as the first CBD brand company to officially cross over into national mainstream distribution across the U.S., providing new access to over 2,400 retail locations in a major distribution channel market valued at over USD $4.1 billion in retail sales.

The NSS exclusive agreement provides access to a national network of retail stores across the U.S. This national network includes major retail banners such as: Whole Foods Market, Sprouts Farmers Market, National Coop Grocers, etc. The partnership also provides the opportunity to access an additional 25,000 national conventional grocery supermarkets, including Walmart, Target, Kroger, Publix and others, via Acosta’s national sales network.

Further Information
+1 (844) 744-6646 (ext. #2)

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.50395, up 7.22%, on 72,824 volume with 26 trades. The average volume for the last 3 months is 132,320 and the stock's 52-week low/high is $0.344/$1.06.

Recent News


QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is pleased to announce during the recent Irgon drill program, Cabot Corp., the owners of the TANCO Mine, provided QMC the opportunity to evaluate and re-sample the stored drill core derived from the 1978 TANCO drill program.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.1684, up 13.17%, on 88,390 volume with 33 trades. The average volume for the last 3 months is 53,386 and the stock's 52-week low/high is $0.1155/$0.496.

Recent News


City View Green Holdings Inc. (CSE: CVGR)

The QualityStocks Daily Newsletter would like to spotlight City View Green Holdings Inc. (CVGR).

City View Green Holdings Inc. (CSE: CVGR) is a vertically integrated cannabis company focused on seed-to-retail offerings. The company's goal is to be a leading purveyor of medicinal and recreational cannabis while providing the most comprehensive and customer-centric user experience and creating a well-diversified company capable of producing long-term results.

City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.


Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

City View Green Holdings Inc. (CSE: CVGR), closed the day's trading session at $0.11, up 4.76%, on 174,220 volume with 22 trades. The average volume for the last 3 months is 338,781 and the stock's 52-week low/high is $0.095/$0.465.

Recent News


Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (OTCQB: SGMD), a major supplier to the growing hydroponic cultivation sector, today announces a new corporate initiative to develop cultivation monitoring systems for hemp and other agricultural commodities. Also today, the company was highlighted in a publication from, examining how cannabis growers, like other agriculturalists, are turning to internet-of-things (IoT) technologies, to bring new efficiencies to their cultivation operations, and improve yields and profits. The impact has been called "seismic" by industry insiders. Additionally, CannabisNewsWire released a report on the company detailing how a boom in demand for cannabidiol (CBD) has created an alarming shortage, which savvy hemp companies are aggressively looking to solve.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include:;; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.


CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.0349, up 2.65%, on 2,085,713 volume with 137 trades. The average volume for the last 3 months is 1,120,965 and the stock's 52-week low/high is $0.03/$0.1975.

Recent News


Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Geyser Brands Inc. (TSXV:GYSR) ("Geyser Brands" or the "Company") is pleased to announce that its acquisition target, Solace Management Group Inc. ("Solace"), has completed the build out of its new production and manufacturing facility located in Coquitlam, BC.

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.


Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed the day's trading session at $0.80, even for the day, on 1,000 volume. The average volume for the last 3 months is 8,630 and the stock's 52-week low/high is $0.61/$0.85.

Recent News


SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (OTC:SING) announces the successful completion of the Asset Purchase Agreement with Direct Solar and AI Live Transfers dated Feb. 22, 2019. Direct Solar is the largest acquisition to date for SinglePoint and instantly puts the company squarely into the renewable energy markets.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis' SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint's bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout's subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original "Shark Tank" member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet's secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary's product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation's largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint's chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.01256, up 1.13%, on 4,030,218 volume with 200 trades. The average volume for the last 3 months is 4,038,778 and the stock's 52-week low/high is $0.0106/$0.068.

Recent News


Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) on Monday announced the release of its financial and operating results for the three and nine months ended March 31, 2019. To view the full press release, visit: Also today, the company was highlighted by Virtual Investor Conferences, which, in partnership with Midtown Partners & Co, LLC, announced the agenda for the upcoming Cannastocks2019 Q1 Virtual lnvestor Conference.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.46, off by 0.68%, on 618,627 volume with 650 trades. The average volume for the last 3 months is 604,024 and the stock's 52-week low/high is $0.85/$2.04.

Recent News


Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Uptick Newswire Stock Day Podcast welcomed Marijuana Company of America, Inc. (MCOA) ("the Company"), a Company that specializes in the development of hemp-based products, as well as the expansion of its business into the growing hemp and cannabis market segments. Director, Robert Coale, joined Stock Day host Everett Jolly.

Marijuana Company of America Inc. (OTC: MCOA) (the "Company") are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.01315, off by 2.59%, on 8,043,033 volume with 542 trades. The average volume for the last 3 months is 12,077,832 and the stock's 52-week low/high is $0.01025/$0.0498.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.